<!DOCTYPE html>
<html>
<head>
    <title>Pak&#xAD;istan to buy 1.2 mil&#xAD;lion doses from Sinopharm as it battles se&#xAD;cond wave - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20210101/281672552563339" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>Pak&#xAD;istan to buy 1.2 mil&#xAD;lion doses from Sinopharm as it battles se&#xAD;cond wave</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20210101/textview" title="The Straits Times - 2021-01-01"><time>2021-01-01</time></a>
        - <span>THE BIG STORY</span>
        - <span role="byline"></span>
    </section>

    <p>ISLAMABAD • Pak­istan will pur­chase 1.2 mil­lion Covid-19 vac­cine doses from China’s Sinopharm, a min­is­ter said yes­ter­day in the first of­fi­cial con­fir­ma­tion of a vac­cine pur­chase by the coun­try as it battles a se­cond wave of in­fec­tion.</p>
    <p>China ap­proved a Covid-19 vac­cine de­vel­oped by an af­fil­i­ate of state-backed phar­ma­ceu­ti­cal gi­ant Sinopharm yes­ter­day, its first ap­proved shot for pub­lic use.</p>
    <p>Pak­istani Min­is­ter for Sci­ence and Tech­nol­ogy Chaudhry Fawad Hus­sain said on Twit­ter: “The Cabi­net Com­mit­tee has de­cided to ini­tially pur­chase 1.2 mil­lion doses of the vac­cine from the Chi­nese com­pany Sinopharm, which will be pro­vided free of cost to front-line work­ers in the first quar­ter of 2021.”</p>
    <p>He told Reuters the pur­chase would be of the vac­cine can­di­date de­vel­oped by Sinopharm’s Bei­jing In­sti­tute of Bi­o­log­i­cal Prod­ucts.</p>
    <p>Pak­istan ear­lier this month ap­proved spend­ing US$150 mil­lion (S$198 mil­lion) to buy Covid-19 vac­cines, ini­tially to cover the most vul­ner­a­ble 5 per cent of the pop­u­la­tion, but did not an­nounce which one it would pro­cure.</p>
    <p>The coun­try of 220 mil­lion peo­ple is in the midst of another spate of in­fec­tions, with 58 deaths on Wed­nes­day, tak­ing its death toll past 10,000. It also re­ported 2,475 new in­fec­tions, tak­ing the to­tal case tally to 479,715.</p>
    <p>Pak­istan is cur­rently run­ning Phase 3 clin­i­cal tri­als for CanSino Bi­o­log­ics’ vac­cine can­di­date, Ad5-nCoV, led by the gov­ern­ment-run Na­tional In­sti­tute of Health.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
